Margin status influence on the outcome of patients treated with breast conserving surgery

Iranian Journal of Cancer Prevention

Volumn 4, Issue 4, 2011, Pages 177-182

  Akbari, M E ^a   Akbari, M ^a   Zirakzadeh, H ^a   Nafisi, N ^a   Heidari, A ^a   Hosseinizadegan, Shirazi F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast neoplasm; Breast conserving surgery; Margin; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; DEMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; RECURRENCE RISK; SURVIVAL RATE; TUMOR VOLUME;

EID: 80053965264     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Akbari M E, Abachizadeh K, Khayamzadeh M, Tabatabaee M, Esnaashari FG, Motlagh A, et al. Cancer in Iran. Qom: Darolfekr, In Persian; 2008.
2. Baselga J, Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat. 1994 Jan; 29(1):127-38.
3. Naghavi M. Iranian annual of national death registration report. Ministry of Health and Medical Education, 2005.
4. Ministry of Health and Medical Education, Health deputy. National Burden of Disease and Injury in I.R.Iran, 2006.
5. Jordan VC. SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst. 2007 Mar 7; 99(5):350-6.
6. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002 Oct 17; 347(16):1233-41.
7. Blichert-Toft M, Nielsen M, Düring M, Møller S, Rank F, Overgaard M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008; 47(4):672-81.
8. Akbari ME, Khayamzadeh M, Khoshnevis SJ, Nafisi N, Akbari A. Five and ten years survival in breast cancer patient's mastectomies vs. breast conserving surgeries personal experience. Iran J Cancer Prev. 2008; 1(2):53-6.
9. Early Breast Cancer Trialists' Collaborative Group. Radiotherapy for early breast cancer. Cochrane Database Syst Rev. 2002;(2): CD003647.
10. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005 Dec 17; 366(9503):2087-106.
11. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1005-15.
12. Kunos C, Latson L, Overmoyer B, Silverman P, Shenk R, Kinsella T, et al. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J. 2006 Jan-Feb; 12(1): 28-36.
13. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breastconserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5):1514-21.
14. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002 Nov; 184(5):383-93.
15. Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol. 2007 Oct; 14(10):2953-60.
16. Noguchi M, Minami M, Earashi M, Taniya T, Miyazaki I, Mizukami Y, Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery. Breast Cancer. 1995 Apr 30; 2(1):27-33.
17. Jobsen JJ, Van Der Palen J, Ong F, Meerwaldt JH. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breastconserving therapy. Acta Oncol. 2007; 46(2):172-80.
18. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, et al. Can patient-, treatment and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer. 2003 May; 39(7):932-44.
19. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006 Mar; 13(3):333-9.
20. Akbari ME, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, Akbari M, Hosseinizadegan Shirazi F. Recurrence and Survival Effect in Breast Conserving Surgery: What are the Predictive and/or Prognostic Factors? 2011 Spring; 4(2): 49-54.
21. Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989 May 15; 63(10):1912-7.
22. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 1995; 31A (9):1425-7.
23. Solin LJ, Recht A, Fourquet A, Kurtz J, Kuske R, McNeese M, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer. 1991 Dec 1; 68(11):2337-44.
24. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009 Apr 1; 27(10):1615-20.
25. Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with earlystage invasive breast cancer treated with breastconserving therapy. Eur J Cancer. 2010 Dec; 46(18):3219-32.
26. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30; 320(13):822-8.
27. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and I1 breast cancer. Eur J Cancer. 1992; 28A (4-5):801-5.
28. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005 Apr; 241(4):629-39.
29. Hardy K, Fradette K, Gheorghe R, Lucman L, Latosinsky S. The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba. J Surg Oncol. 2008 Nov 1; 98(6):399-402.
30. Zavagno G, Goldin E, Mencarelli R, Capitanio G, Del Bianco P, Marconato R, et al. Role of resection margins in patients treated with breast conservation surgery. Cancer. 2008 May 1; 112(9):1923-31.
31. Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, et al. The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat. 2009 Jan; 113(2):397-402.
32. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breastconserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000 Apr; 18(8):1668-75.
33. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998 Jan-Feb; 48(1):6-29.
34. Nomura K, Sobue T, Nakatani H, Maehara H. Cancer statistics in Japan 2005 Tokyo-Japan foundation for promotion cancer research, 2005.